HIGHLIGHTS
- who: AC et al. from the Suzuka University of Medical Science, Suzuka-city, Mie, Japan have published the research: Edoxaban, a Factor Xa-Speci fi c Direct Oral Anticoagulant, Signi cantly Suppresses Tumor Growth in Colorectal Cancer Colon26-Inoculated BALB/c Mice, in the Journal: (JOURNAL)
- what: This study was aimed at investigating the effect of DOACs, which target thrombin or factor Xa, on tumor growth in a syngeneic mouse model comprising BALB/c mice inoculated with colon cancer Colon26 cells. The next study was focused on investigating the mechanism underlying the antitumor action of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.